Amundi STOXX Europe 600 Healthcare UCITS ETF Acc (HLT) financial statements and ratios from SEC XBRL: revenue $12.04B (TTM), net margin 12.1%, revenue growth 6.5% YoY, P/E 46.8. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (TTM) | $12.04B |
| Net Margin | 12.1% |
| Revenue Growth (YoY) | 6.5% |
| EPS Growth (YoY) | 14.6% |
| FCF Growth (YoY) | -27.6% |
| P/E Ratio | 46.8 |
| EV / EBITDA | 23.5 |
| Price / Sales | 5.94 |
| FCF Yield | 2.7% |
| DCF Value (model) | $311.12 |
| DCF Upside vs Price | -5.6% |
| Altman Z-Score | 3.06 (safe) |
| Sector P/E (Consumer Discretionary) | 20.5 |
HLT overview · HLT earnings · HLT KPIs · HLT investor relations · HLT ownership · HLT peers · HLT filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.